Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $556.0300 (0.15%) ($542.1550 - $556.4650) on Mon. Sep. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.17% (three month average) | RSI | 34 | Latest Price | $556.0300(0.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN declines -2.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(53%) XLV(44%) SPLV(38%) IVW(37%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -1.085% in a week (0% probabilities). VIXM(-21%) IGOV(-9%) VXX(-7%) UUP(-7%) TBT(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.085% (StdDev 2.17%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $580.34 | 5 Day Moving Average | $564.99(-1.59%) | 10 Day Moving Average | $561.59(-0.99%) | 20 Day Moving Average | $580.34(-4.19%) | To recent high | -15.5% | To recent low | 2.1% | Market Cap | $58.955b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |